Literature DB >> 26721797

The comparative efficacy of tyloxapol versus pentoxifylline against induced acute phase response in an ovine experimental endotoxemia model.

Aliasghar Chalmeh1, Alireza Rahmani Shahraki2, Seyed Mohammad Mehdi Heidari2, Khalil Badiei2, Mehrdad Pourjafar2, Saeed Nazifi2, Mohammad Javad Zamiri3.   

Abstract

The effective treatments of endotoxemia are necessary to prevent high mortality rates. Hence, the present study was performed to clarify the antiendotoxic effects of tyloxapol and pentoxifylline in experimentally induced endotoxemia in sheep. Thirty clinically healthy 1-year-old Iranian fat-tailed ewes were randomly divided into six equal experimental (n = 5) groups, comprising Negative and Positive control, Tyloxapol 1, Tyloxapol 2, Pentoxifylline 1 and Pentoxifylline 2. Phenol extracted lipopolysaccharide from Escherichia coli serotype O55:B5 was infused at 2 µg/kg intravenously. Tyloxapol (200 and 400 mg/kg) and pentoxifylline (30 and 60 mg/kg) were injected to Tyloxapol and Pentoxifylline groups, respectively, at 90 min after endotoxemia induction over 60 min along with intravenous fluids. Blood samples were collected from all ewes prior and 1.5, 3, 4.5, 6, 24 and 48 h after lipopolysaccharide injection and sera and plasmas were separated, subsequently. Haptoglobin, serum amyloid A, tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), superoxide dismutase and glutathione peroxidase were measured in all samples. Serum concentrations of haptoglobin, serum amyloid A, TNF-α and IFN-γ in Tyloxapol 1 and 2 and Pentoxifylline 1 and 2 groups were significantly lower than Positive control one after hour 3. There were no significant differences among Tyloxapol and Pentoxifylline groups (P > 0.05). Superoxide dismutase and glutathione peroxidase activities in Tyloxapol 1 and 2 and Pentoxifylline 1 and 2 groups were significantly lower than Positive control one after hour 3. There were no significant differences among Tyloxapol 1 and 2 and Pentoxifylline 1 and 2 groups (P > 0.05). Tyloxapol and pentoxifylline act as the anti-inflammatory mediators by decreasing pro-inflammatory cytokines and hepatic APPs and modulating oxidative enzymes activity after endotoxemia induction in sheep. Furthermore, their efficacies at different doses were significantly similar together and both drugs don't induce their effects by dose dependent manner and the anti- and pro-inflammatory effects of them were statistically similar.

Entities:  

Keywords:  Endotoxemia; Inflammatory responses; Pentoxifylline; Sheep; Treatment; Tyloxapol

Mesh:

Substances:

Year:  2015        PMID: 26721797     DOI: 10.1007/s10787-015-0257-9

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  24 in total

Review 1.  Current research on acute phase proteins in veterinary diagnosis: an overview.

Authors:  H Murata; N Shimada; M Yoshioka
Journal:  Vet J       Date:  2004-07       Impact factor: 2.688

Review 2.  Reactive oxygen species as mediators of tissue protection and injury.

Authors:  V Bauer; F Bauer
Journal:  Gen Physiol Biophys       Date:  1999-10       Impact factor: 1.512

3.  Identification of a novel tumor necrosis factor alpha/cachectin from the livers of burned and infected rats.

Authors:  C Keogh; Y Fong; M A Marano; S Seniuk; W He; A Barber; J P Minei; D Felsen; S F Lowry; L L Moldawer
Journal:  Arch Surg       Date:  1990-01

4.  Use of detergent to prevent initial responses to endotoxin in horses.

Authors:  K E Longworth; B L Smith; N C Staub; E P Steffey; V B Serikov
Journal:  Am J Vet Res       Date:  1996-07       Impact factor: 1.156

5.  The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat.

Authors:  Omar M E Abdel-Salam; Ayman R Baiuomy; Siham M El-Shenawy; Mahmoud S Arbid
Journal:  Pharmacol Res       Date:  2003-04       Impact factor: 7.658

6.  Tyloxapol inhibits NF-kappa B and cytokine release, scavenges HOCI, and reduces viscosity of cystic fibrosis sputum.

Authors:  A J Ghio; B C Marshall; J L Diaz; T Hasegawa; W Samuelson; D Povia; T P Kennedy; C A Piantodosi
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

Review 7.  The changing faces of glutathione, a cellular protagonist.

Authors:  Alfonso Pompella; Athanase Visvikis; Aldo Paolicchi; Vincenzo De Tata; Alessandro F Casini
Journal:  Biochem Pharmacol       Date:  2003-10-15       Impact factor: 5.858

8.  Anti-inflammatory effects of insulin regular and flunixin meglumine on endotoxemia experimentally induced by Escherichia coli serotype O55:B5 in an ovine model.

Authors:  Aliasghar Chalmeh; Khalil Badiei; Mehrdad Pourjafar; Saeed Nazifi
Journal:  Inflamm Res       Date:  2012-09-09       Impact factor: 4.575

9.  Study of pentoxifylline induced modulation of TNF alpha and interleukin-6 secretion in healthy and septic patients by the use of an ex-vivo model on whole blood.

Authors:  J Bienvenu; L Coulon; Y Barbier; M Barbier; C Doche; A Lepape; M Guenounou
Journal:  Nouv Rev Fr Hematol       Date:  1992

10.  Is sepsis-induced apoptosis associated with macrophage dysfunction?

Authors:  A Ayala; M A Urbanich; C D Herdon; I H Chaudry
Journal:  J Trauma       Date:  1996-04
View more
  2 in total

1.  A Neonatal Murine Escherichia coli Sepsis Model Demonstrates That Adjunctive Pentoxifylline Enhances the Ratio of Anti- vs. Pro-inflammatory Cytokines in Blood and Organ Tissues.

Authors:  Esther M Speer; Elizabet Diago-Navarro; Lukasz S Ozog; Mahnoor Raheel; Ofer Levy; Bettina C Fries
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

2.  Antenatal pentoxifylline therapy to prevent endotoxin-induced fetal injury in the preterm goat model.

Authors:  Mekin Sezik; Afşin Köker; Özlem Özmen; Mehmet Halıgür; Duygu Kaşıkcı; Ahmet Aydoğan; Orhan Özatik
Journal:  Turk J Obstet Gynecol       Date:  2020-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.